Charles River Laboratories International (CRL) Revenue: 2009-2025
Historic Revenue for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $1.0 billion.
- Charles River Laboratories International's Revenue fell 0.49% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year decrease of 0.92%. This contributed to the annual value of $4.0 billion for FY2024, which is 1.92% down from last year.
- Charles River Laboratories International's Revenue amounted to $1.0 billion in Q3 2025, which was down 2.64% from $1.0 billion recorded in Q2 2025.
- Charles River Laboratories International's Revenue's 5-year high stood at $1.1 billion during Q4 2022, with a 5-year trough of $824.6 million in Q1 2021.
- Over the past 3 years, Charles River Laboratories International's median Revenue value was $1.0 billion (recorded in 2023), while the average stood at $1.0 billion.
- In the last 5 years, Charles River Laboratories International's Revenue spiked by 33.99% in 2021 and then dropped by 7.85% in 2023.
- Quarterly analysis of 5 years shows Charles River Laboratories International's Revenue stood at $905.0 million in 2021, then rose by 21.52% to $1.1 billion in 2022, then declined by 7.85% to $1.0 billion in 2023, then declined by 1.08% to $1.0 billion in 2024, then dropped by 0.49% to $1.0 billion in 2025.
- Its Revenue was $1.0 billion in Q3 2025, compared to $1.0 billion in Q2 2025 and $984.2 million in Q1 2025.